Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Jul 13;20(6):1374–1381.e6. doi: 10.1016/j.cgh.2021.07.016

TABLE 3:

Showing the Hazard Ratio for development of cirrhosis, decompensation events, any cardiovascular event, malignancy, and death, with reference to obese NAFLD, by univariate or multivariable analysis (adjusted for sex, diabetes, HTN, and dyslipidemia).

Variable Normal Overweight
HR 95% CI P HR 95% CI P
Cirrhosis
 Univariate 0.33 0.1–1.05 0.06 0.81 0.51–1.29 0.37
 Multivariable - - - - - -
Decompensation
 Univariate 0.79 0.11–5.79 0.82 0.52 0.22–1.22 0.13
 Multivariable - - - - - -
Any CV event
 Univariate 1.05 0.73–1.51 0.78 0.97 0.77–1.23 0.81
 Multivariable 1.23 0.85–1.78 0.28 0.92 0.72–1.17 0.49
Malignancy
 Univariate 0.87 0.51–1.48 0.61 1.29 0.98–1.71 0.07
 Multivariable 0.79 0.46–1.36 0.40 1.10 0.82–1.46 0.53
Death
 Univariate 1.96 1.52–2.51 <0.001 1.23 1.02–1.49 0.03
 Multivariable 1.63 1.25–2.13 <0.001 0.99 0.81–1.2 0.90